文献速递白血病

scaRNA12失调对B细胞前体急性淋巴细胞白血病p53介导细胞应激反应的影响

The impact of scaRNA12 deregulation on p53-mediated cellular stress response in B-cell precursor acute lymphoblastic leukaemia.
PubMed 文献 · Br J Haematol · 2026-01-19

本研究探讨snoRNA在B细胞前体急性淋巴细胞白血病(BCP-ALL)中的作用,发现30个snoRNA常见失调,其中scaRNA12下调最显著。强制表达scaRNA12可恢复U5 snRNA的U5:Ψ46假尿苷化,激活p53并增强化疗敏感性,提示scaRNA12具有抑癌作用。

要点

  • BCP-ALL中scaRNA12表达显著下调,为下调最明显的snoRNA。
  • scaRNA12强制表达恢复U5:Ψ46修饰并激活p53通路。
  • scaRNA12表达增强BCP-ALL细胞对化疗药物的敏感性。

核心结论

  • scaRNA12在BCP-ALL中可能发挥抑癌作用。

研究设计与样本

  • 研究检测了BCP-ALL中snoRNA表达谱,并在BCP-ALL细胞中进行scaRNA12强制表达的功能实验。

主要发现

  • 30个snoRNA在BCP-ALL中常见失调,scaRNA12下调最显著。
  • scaRNA12强制表达 largely 恢复U5 snRNA的U5:Ψ46假尿苷化水平。
  • scaRNA12调控一组属于BCP-ALL常见受累通路的基因。
  • scaRNA12激活p53,并降低上游p53调控因子的表达。
  • scaRNA12强制表达增加p53活性并显著增强BCP-ALL对化疗试剂的敏感性。

临床怎么用

  • scaRNA12表达水平可能作为BCP-ALL中p53通路状态和化疗敏感性的潜在生物标志物。
  • 恢复scaRNA12功能或可成为增强BCP-ALL化疗敏感性的策略方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Small nucleolar ribonucleic acids (snoRNAs) are a class of small non-coding RNAs involved in the post-transcriptional modification of ribosomal RNAs (rRNA) and small nuclear RNAs (snRNA). Mounting evidence indicates that specific snoRNAs are drivers of oncogenesis, but their role in B-cell precursor acute lymphoblastic leukaemia (BCP-ALL) is unknown. We found that a small subset of 30 snoRNAs is commonly deregulated in BCP-ALL. Small Cajal body-specific RNA 12 (scaRNA12) was the strongest downregulated snoRNAs in BCP-ALL. Forced expression of scaRNA12 in BCP-ALL cells largely recovered the level of uridine-46 pseudouridylation of U5 snRNA (U5:Ψ46), an important RNA modification for proper splicing and gene expression regulation. We found that scaRNA12 controls a set of genes that belong to pathways that are frequently affected in BCP-ALL samples. We show that scaRNA12 activates p53, which is commonly affected in BCP-ALL even in the absence of p53 mutations. We show that scaRNA12 expression decreased the expression of upstream p53 regulators and provide novel evidence for a role of scaRNA12 in p53 regulation. We found that forced expression of scaRNA12 in BCP-ALL increased p53 activity and significantly enhanced the sensitivity of BCP-ALL to chemotherapeutic reagents. Together, our results suggest a tumour-suppressing role for scaRNA12 in BCP-ALL.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Verbeek MWC, Sanders MA, Grashof DGB, et al. The impact of scaRNA12 deregulation on p53-mediated cellular stress response in B-cell precursor acute lymphoblastic leukaemia. Br J Haematol. 2026. PMID: 41550039. doi:10.1111/bjh.70336

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。